Literature DB >> 11070120

Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia.

H L Evans1, E Burks, D Viswanatha, R S Larson.   

Abstract

Although T-lineage large granular lymphocyte (LGL) leukemia has been described for over 20 years, many patients with this neoplasm go unrecognized. Chief among the difficulties in diagnosing this entity is that the morphologic features are nonspecific and that it is difficult to distinguish it from reactive processes. The purpose of this study was to examine the histologic and immunophenotypic appearance of T-LGL leukemia in the peripheral blood and bone marrow, and to determine what features may suggest that ancillary studies such as flow cytometric and molecular analysis should be pursued to make a definitive diagnosis. We took a multidisciplinary approach by using morphology, immunoperoxidase staining, flow cytometric analysis, and molecular studies on 9 cases of T-lineage LGL leukemia. Our findings indicate that T-lineage LGL leukemia typically infiltrates the marrow diffusely. Most cases show a hypercellular marrow with an increase in myeloid precursors relative to the mature cells (i.e., an inversion of the myeloid maturation pyramid) and a decreased myeloid:erythroid ratio. Neutropenia without a left shift is usually seen in the peripheral blood. The tumor cells are usually CD3+, CD8+, CD57+, and TIA-1+. Most notably, the number of CD3+ T cells per high-power field is markedly elevated in T-LGL leukemia compared with normal, reactive, and pathologic marrows with neutropenia (mean values, 559 cells/mm(2) v. 7/mm(2), 11/mm(2), and 263/mm(2), respectively, P<.01). Moreover, CD57 staining also shows an increase in positive cells in T-LGL cases in comparison with normal, reactive, and pathologic marrows with neutropenia. Taken together, these findings indicate immunoperoxidase findings may be a useful tool to identify cases that should proceed to molecular or flow cytometric analysis.

Entities:  

Mesh:

Year:  2000        PMID: 11070120     DOI: 10.1053/hupa.2000.19298

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.

Authors:  E Poullot; R Zambello; F Leblanc; B Bareau; E De March; M Roussel; M L Boulland; R Houot; A Renault; T Fest; G Semenzato; T Loughran; T Lamy
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

2.  STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.

Authors:  Andres Jerez; Michael J Clemente; Hideki Makishima; Hanna Rajala; Ines Gómez-Seguí; Thomas Olson; Kathy McGraw; Bartlomiej Przychodzen; Austin Kulasekararaj; Manuel Afable; Holleh D Husseinzadeh; Naoko Hosono; Francis LeBlanc; Sonja Lagström; Dan Zhang; Pekka Ellonen; André Tichelli; Catherine Nissen; Alan E Lichtin; Aleksandra Wodnar-Filipowicz; Ghulam J Mufti; Alan F List; Satu Mustjoki; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2013-08-07       Impact factor: 22.113

3.  Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.

Authors:  Cédric Pastoret; Fabienne Desmots; Gaëlle Drillet; Simon Le Gallou; Marie-Laure Boulland; Alexia Thannberger; Anne-Violaine Doncker; Véronique Salaun; Gandhi Laurent Damaj; Richard Veyrat-Masson; Olivier Tournilhac; Aline Moignet; Céline Pangault; Mikaël Roussel; Thierry Fest; Thierry Lamy
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476

Review 4.  Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.

Authors:  Giulia Calabretto; Antonella Teramo; Gregorio Barilà; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Gianpietro Semenzato; Renato Zambello
Journal:  Cells       Date:  2021-10-19       Impact factor: 6.600

5.  STAT3 mutations in "gray-zone" cases of T-cell large granular lymphocytic leukemia associated with autoimmune rheumatic diseases.

Authors:  Vadim Gorodetskiy; Yulia Sidorova; Bella Biderman; Natalia Kupryshina; Natalya Ryzhikova; Andrey Sudarikov
Journal:  Front Med (Lausanne)       Date:  2022-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.